dr. kluger on toxicity of nivolumab/ ipilimumab for advanced melanoma
Published 9 years ago • 501 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:45
dr. kluger on the toxicity profile of concurrent nivolumab and ipilimumab
-
0:46
dr. kluger on a phase i trial of concurrent nivolumab and ipilimumab for advanced melanoma
-
2:10
dr. weber on the toxicity profile of nivolumab versus ipilimumab for melanoma
-
1:34
dr. sharpless on managing toxicities with nivolumab/ipilimumab in melanoma
-
1:02
dr. hodi on nivolumab in combination with ipilimumab for advanced melanoma
-
5:39
nivolumab plus ipilimumab in advanced melanoma
-
1:47
dr. sznol on combining nivolumab and ipilimumab for the treatment of advanced melanoma
-
1:27
dr. kluger on how immunotherapies are changing the treatment of melanoma
-
1:24
dr. ernstoff discusses nivolumab and ipilimumab in advanced melanoma
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
1:37
dr. kluger on the changing landscape of immunotherapies for the treatment of melanoma
-
1:55
dr. jeffrey weber on ipilimumab for melanoma
-
1:00
dr. sznol on immune-related toxicities in melanoma
-
1:57
dr. luke discusses the controversy surrounding ipilimumab/nivolumab combo in melanoma
-
1:21
dr. kluger on immunotherapy in melanoma
-
1:59
dr. sznol on combining nivolumab and ipilimumab for the treatment of advanced melanoma
-
2:10
ipilimumab combined with nivolumab for patients with melanoma
-
1:15
dr. postow on nivolumab combined with ipilimumab in melanoma
-
1:31
dr. kluger on toxicities associated with immunotherapies